Sylics starts-up a new location to expand our services and to support your CNS disease research

The ongoing COVID-19 pandemic and again rising infection numbers is affecting all of us personally and our businesses. In this situation, Sylics is focused to continue and expand our support for clients and partners in CNS research. The opening of a new location ensures that we are able to offer you our full range of CNS screening services even during these challenging times. At this new location will be able to broaden our services portfolio and to be more flexible to meet the needs of you, our customers. More information will follow in due time